【一期一会】五月浅夏，盛会如约 | Your May Guide to Industry Events

Tips

五月初夏，盛会如约。美迪西将参与1场线上直播，并出席7场国内外重磅会议，与您线上线下相见。我们期待与您在这场知识与智慧的盛宴中交流互鉴，激荡前沿洞察，为您的研发征程注入新动能。

5月14日晚，余小磊 美迪西制剂部分析助理主任，主题：多肽制剂的质量研究

Swiss Biotech Day 2026

May 4-5, 2026
Congress Center Basel, Switzerland

As one of Europe‘s most influential biotech gatherings, Swiss Biotech Day is expected to bring together 3,000+ life sciences experts from 49 countries, 130+ exhibitors, and ~30 international delegations. Key topics include R&D innovation, advanced manufacturing, AI, and novel financing models.

Dr. Wei Hu, Director BD Europe at Medicilon, will attend in person. He looks forward to exploring collaboration opportunities with global partners.

Let’s connect in Basel.

SAPA‑GP 2026 Cell & Gene Therapy Symposium

May 8-9, 2026
Sheraton Valley Forge Hotel
480 N Gulph Rd, King of Prussia, PA 19406

This symposium brings together industry experts, researchers, and business leaders to discuss the latest advances in CGT development, cutting-edge technologies, and clinical translation. We are  excited to announce that Medicilon expert will deliver a featured presentation.

Medicilon’s CGT platform covers CAR‑T, TCR‑T, CAR‑NK, and TIL cells, supported by diverse animal models and advanced analytics. Through strategic collaborations with industry leaders such as Hengrui Pharma and ZY Therapeutics, we continue to drive innovation in nucleic acid therapeutics, gene therapy, and cell‑based modalities. With over 100 IND approvals supported in 2025 alone, we are a trusted partner for global drug development.

2026CBA-China中国年会

2026年5月8-10日
无锡国际会议中心
美迪西展位 #D48号

全球生物医药产业格局深度变革，创新技术与监管挑战并行。由美国华人生物医药科技协会中国分会（CBA-China）主办、佰傲谷BioValley承办的2026 CBA-China中国年会，将于5月8-10日在无锡国际会议中心盛大启幕。大会以“破局共生，创健未来——应对全球变局，共筑药物创新与可及性的新生态”为主题，汇聚近300海内外权威嘉宾、4000+产业精英，精心打造13大平行论坛，覆盖早期研发、临床转化、全球注册、CGT、ADC、AI制药、投融资BD等全产业链核心赛道。从前沿技术解析到产业政策解读，从项目对接到资本合作，全方位呈现全球医药创新生态，为行业同仁奉上一场高规格、全维度、深干货的年度思想盛宴。

❖ 5月9日，美迪西高级主任&生物技术药物分析部负责人章登吉博士将在细胞治疗论坛分享“In vivo CAR-T临床前研究考虑点的生物分析视角与技术实践”。

❖ 5月10日，美迪西临床前研究副总裁曾宪成博士将在基因治疗论坛参与圆桌论坛。美迪西将在D48全程设展，诚邀您莅临现场交流！

Nordic Precision Medicine Forum 2026 (Nordic PMF 2026)

May 11-12, 2026
Elite Hotel Marina Tower, Stockholm, Sweden

A key Nordic event focused on precision diagnostics, biomarker‑driven therapies, and translational medicine.

Dr. Paul van Stralen, VP Strategic Collaborations EMEA, and Dr. Jian Liu, VP of Business Development, will represent Medicilon. They look forward to engaging with Nordic and European partners to accelerate precision medicine programs - from target validation to IND‑enabling studies, with deep expertise in oncology, immunology, CNS, and novel modalities.
See you in Stockholm.

AAPS National Biotechnology Conference (NBC 2026)

May 11-14, 2026
Sheraton San Diego Resort, San Diego, CA
Booth#508

This premier scientific event covers the latest in biologics, advanced therapies, and biotherapeutic development. The 2026 program features two thematic tracks: Applying Translational Principles Across the Development Lifecycle and Advancing Novel Medicine through Precision Science and Patient‑Centric Innovation (including AI/ML, global regulatory harmonization, and precision medicine).

Visit Medicilon at Booth #508. Medicilon team looks forward to connecting with global biotech and pharma partners to explore how our integrated preclinical CRO platform can accelerate your biologics and advanced therapy programs. Stop by to learn how our GLP‑compliant pharmacology, DMPK, bioanalysis, toxicology, and large animal models can support your next IND.

49th Korean Society of Nonclinical Study (KSNS) Spring Workshop

May 29th(Fri) / 1day
Suwon Convention Center, Gyeonggi-do Province

Organized by the Korean Society of Nonclinical Study (KSNS), this year‘s workshop features special sessions on gene and cell therapy, safety and efficacy research, and advances in targeted protein degradation (TPD), ADCs, and therapeutic peptides.

Mr. Haiming Tang will lead the Medicilon team. With over 30 years of U.S. preclinical experience at Roche, Novartis, Relay Therapeutics, and Degron Therapeutics, Mr. Tang brings deep expertise in preclinical safety assessment strategies across cardiovascular, metabolic, autoimmune, and oncology diseases, with strong regulatory knowledge of FDA/EMA IND requirements.

Let’s connect in Suwon. Reach out to Mr. Tang directly to schedule a meeting.

74th American Society for Mass Spectrometry (ASMS 2026)

May 31 - June 4, 2026
San Diego Convention Center,  San Diego, CA

We are excited to announce that Medicilon will participate in the 74th ASMS Conference.

Mass spectrometry plays an extremely important role in DMPK and bioanalysis, with key applications in DMPK including metabolite identification, PK parameter determination, drug-drug interaction studies, and more, while its core roles in bioanalysis encompass protein drug analysis, biomarker detection, and more.

Visit us at ASMS 2026 to connect with Medicilon's DMPK experts and discover how our mass spectrometry capabilities support your DMPK and bioanalysis programs.

marketing@medicilon.com
媒体与会务请联系
美迪西市场部微信或邮箱